Bayer, DelSiTech partner to develop new drug delivery technology for ophthalmology
Bayer and DelSiTech have partnered to develop innovative drug delivery technology for ophthalmology.
The companies have signed a collaboration and technology licence agreement for the worldwide application of DelSiTech’s Silica Matrix drug delivery platform to a number of Bayer’s compounds in ophthalmology.
Click on this link for more information.
